TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
IRWD

Ironwood Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.10$ -1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Ironwood Pharmaceuticals Inc (IRWD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 113 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IRWD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
114 118 75 94 92 91 41 85 122 48 107 113 389
0.5 0.5 26 0.5 30 78 27 0.5 0.5 0.5 0.4 – –
113 118 49 94 62 91 14 85 122 48 106 113 388
32 36 26 30 30 25 27 23 22 22 21 22 88
36 39 38 37 36 34 24 17 22 19 12 11 65
65 80 38 69 36 59 43 40 44 41 34 34 152
49 38 11 25 26 31 -29 45 78 6.6 73 79 236
9.8 8.4 7.2 7.5 9.4 8.9 8.1 8.4 8.4 7.9 9.1 7.2 33
32 30 5.0 19 17 24 -36 38 68 0.5 65 74 207
18 32 9.1 20 14 22 1.1 14 28 2.7 24 22 78
15 -1.1 -4.2 -0.9 3.6 2.3 -37 24 40 -2.3 41 51 130
42 41 12 27 27 33 -10 47 77 8.8 75 81 241

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?